Umar Farooq
Impact in
- Oncology top 0.2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 45
- Oncology 41
- CAR-T cell therapy research 29
- Cancer survivorship and care 6
- Co-authors
- Matthew J. Maurer (28 shared papers)James R. Cerhan (27 shared papers)Brian K. Link (20 shared papers)Christian Gisselbrecht (5 shared papers)Michael Crump (5 shared papers)Sattva Swarup Neelapu (7 shared papers)John G. Kuruvilla (5 shared papers)Lynn Navale (6 shared papers)
- Journals
- Blood (22 papers)Transplantation and Cellular Therapy (15 papers)Blood Advances (11 papers)British Journal of Haematology (8 papers)American Journal of Hematology (6 papers)
- Partner nations
- United StatesPakistanCanada
In The Last Decade
Umar Farooq
157 papers receiving 12.6k citations
Umar Farooq's Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 7.6k
- Pathology and Forensic Medicine 3.1k
- Hematology 635
- Transplantation 157
- Immunology 530
Countries citing papers authored by Umar Farooq
This map shows the geographic impact of Umar Farooq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umar Farooq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umar Farooq more than expected).
Fields of papers citing papers by Umar Farooq
This network shows the impact of papers produced by Umar Farooq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umar Farooq. The network helps show where Umar Farooq may publish in the future.
Co-authors
The 25 scholars most cited alongside Umar Farooq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 170 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma Hit paper breakdown → | 2017 | 4779 |
| 2 | Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial Hit paper breakdown → | 2018 | 1879 |
| 3 | Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study Hit paper breakdown → | 2017 | 1352 |
| 4 | Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma Hit paper breakdown → | 2021 | 1164 |
| 5 | Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma Hit paper breakdown → | 2023 | 310 |
| 6 | 5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1) Hit paper breakdown → | 2023 | 186 |
| 7 | 2021 | 177 | |
| 8 | Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis Hit paper breakdown → | 2022 | 170 |
| 9 | 2013 | 168 | |
| 10 | 2018 | 120 | |
| 11 | JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma Hit paper breakdown → | 2024 | 119 |
| 12 | 2016 | 113 | |
| 13 | 2018 | 109 | |
| 14 | 2013 | 101 | |
| 15 | 2017 | 99 | |
| 16 | 2021 | 84 | |
| 17 | 2017 | 76 | |
| 18 | 2016 | 73 | |
| 19 | 2021 | 70 | |
| 20 | 2019 | 65 |
About Umar Farooq
Umar Farooq is a scholar working on Pathology and Forensic Medicine, Oncology, Transplantation, Hematology and Neurology, having authored 170 papers that have together received 13k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (45 papers), CAR-T cell therapy research (29 papers), Renal Transplantation Outcomes and Treatments (11 papers), Hematopoietic Stem Cell Transplantation (10 papers), CNS Lymphoma Diagnosis and Treatment (8 papers), Multiple Myeloma Research and Treatments (7 papers), Cancer survivorship and care (6 papers) and Transplantation: Methods and Outcomes (5 papers). The work is most often cited by research in Oncology (7.6k citations), Pathology and Forensic Medicine (3.1k citations), Hematology (635 citations), Transplantation (157 citations) and Immunology (530 citations). Umar Farooq has collaborated with scholars based in United States, Pakistan and Canada. Frequent co-authors include Matthew J. Maurer, James R. Cerhan, Brian K. Link, Christian Gisselbrecht, Michael Crump, Sattva Swarup Neelapu, John G. Kuruvilla, Lynn Navale, Lei Feng and Jason R. Westin. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Blood Advances, British Journal of Haematology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.